Trial · NCT05263388
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Oocytes Retrieved | On day of oocyte retrieval (Up to 22 days after start of stimulation) | The number of oocytes retrieved was recorded at the oocyte retrieval visit. |
| Secondary | Number of Follicles (Total) at End-of-stimulation | At end-of-stimulation (up to 20 stimulation days) | Counted by transvaginal ultrasound for the right and left ovary for each subject. |
| Secondary | Size of the Follicles at End-of-stimulation | At end-of-stimulation (up to 20 stimulation days) | Counted by ultrasound for the right and left ovary for each subject. |
| Secondary | Serum Concentrations of Estradiol at End-of-stimulation | At end-of-stimulation (up to 20 stimulation days) | Blood samples for analysis of circulating concentrations of estradiol were drawn. |
| Secondary | Serum Concentrations of Progesterone at End-of-stimulation | At end-of-stimulation (up to 20 stimulation days) | Blood samples for analysis of circulating concentrations of progesterone were drawn. |
| Secondary | Number of Fertilized Oocytes | On day 1 after oocyte retrieval (up to 23 days after start of stimulation) | The number of pronuclei were counted after insemination. Fertilized oocytes with 2 pronuclei (2PN) were regarded as correctly fertilized. |
| Secondary | Fertilization Rate | On day 1 after oocyte retrieval (up to 23 days after start of stimulation) | The fertilization rate was defined as the number of oocytes with 2PN divided by the number of oocytes retrieved. |
| Secondary | Number of Blastocysts and Number of Good Quality Blastocysts | On Day 5 or Day 6 (as applicable) after oocyte retrieval (up to 27 or 28 days after start of stimulation) | Number of blastocysts and number of good quality blastocysts on Day 5 or 6 were presented. The quality evaluation of blastocysts consisted of assessment of three parameters, as per the Gardner \& Schoolcraft system: blastocyst expansion and hatching status (graded: 1-6), inner cell mass (graded: A-D) and trophectoderm (graded: A-D). A good-quality blastocyst was defined as a blastocyst of grade 3BB or higher. |
| Secondary | Total Gonadotropin Dose | Up to 20 stimulation days | Calculated by start dates, end dates and daily dose of investigational medicinal product (IMP). |
| Secondary | Number of Stimulation Days | Up to 20 stimulation days | Calculated by start dates and end dates. |
| Secondary | Proportion of Subjects With Early Ovarian Hyperstimulation Syndrome (OHSS) (Overall and by Grade) and/or Preventive Interventions for Early OHSS | Up to 9 days after triggering of final follicular maturation | Early OHSS is defined as OHSS with onset ≤9 days after triggering of final follicular maturation. Classification of grade was according to Golan's classification system, and all OHSS cases were graded as mild, moderate or severe. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05263388/registered